Under these conditions, the administration of any of the treatments deriving from S. schiedeana caused a significant diminution of cytokines IL-1β and IL-17 (both comprise key factors of inflammation during RA), and also of IL-6 on joint tissue. This evidence concerns the gene IL17A and rheumatoid arthritis.